Zomedica (ZOMDF) Receivables (2016 - 2026)
Zomedica (ZOMDF) reported Receivables of $7.18 million for Q3 2026, up 97.7% from $3.63 million a year earlier and up 19.1% from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Receivables (2016 - 2026) Analysis & Trends
At the end of FY2025, Zomedica posted Receivables of $3.46 million, up 12.5% from FY2024.
- Receivables has increased for nine consecutive years, with a five-year compound annual growth rate of 88.2% (FY2020 to FY2025).
- By year, Receivables came in at $3.07 million in FY2024 (+39.7%), $2.2 million in FY2023 (+17.9%), $1.86 million in FY2022 (+143.7%) and $765,000 in FY2021 (+423.2%).
- The Q3 2026 figure ranks as the highest quarterly Receivables since Q2 2017.
- Year over year, Receivables has now increased in each of the last six quarters, with growth averaging 57.6% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q3 2022 (growth of 577.4%); the low point was Q1 2025 (a decline of 12.6%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $6.03 million (Q2 2026), $4.8 million (Q1 2026) and $3.46 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Zomedica | 97.99 Mn | -87.03 Mn | 6.04 Mn | 7.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.18 Mn |
| Jun 30, 2026 | 6.03 Mn |
| Mar 31, 2026 | 4.80 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 2.11 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 1.80 Mn |
| Jun 30, 2022 | 828,000.00 |
| Mar 31, 2022 | 811,000.00 |
| Dec 31, 2021 | 765,000.00 |
API Access
Zomedica Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();